The epidemiology of invasive pneumococcal disease in older adults in the post-PCV era. Has there been a herd effect?
| Autor: | Jolita Mereckiene, Mary Cafferkey, Martha McElligott, S. Murchan, D O'Flanagan, Suzanne Cotter, M Fitzgerald, I. Vickers, Robert Cunney, Mary Corcoran, Hilary Humphreys |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Serotype
Pediatrics medicine.medical_specialty Epidemiology 030231 tropical medicine Rate ratio Pneumococcal Infections Herd immunity Pneumococcal Vaccines 03 medical and health sciences 0302 clinical medicine Humans Medicine 030212 general & internal medicine Aged Aged 80 and over business.industry Incidence (epidemiology) Original Papers Pneumococcal polysaccharide vaccine Vaccination Streptococcus pneumoniae Infectious Diseases Vaccine-preventable diseases business Ireland |
| Zdroj: | Epidemiol Infect |
| ISSN: | 1469-4409 0950-2688 |
| Popis: | SUMMARYThe 7 and 13-valent pneumococcal conjugate vaccines (PCVs) have reduced the incidence of invasive pneumococcal disease (IPD) in children in many countries. The objective of this work was to assess the impact of PCVs and potential herd-protection in older adults in Ireland. IPD notification and typing data from adults ⩾65 years of age from July 2007 to June 2016 was assessed using national surveillance data. There was a 94% reduction in PCV7 serotypes from 2007–2008 to 2015–2016, incidence rate ratio (IRR 0·05, P < 0·0001). However, there was no decline in the additional PCV13 (PCV13-7) serotypes over the same period (IRR 0·90) nor in comparison with the pre-PCV13 period 2009–2010 (IRR 0·92). The incidence of serotypes in the 23-valent pneumococcal polysaccharide vaccine only (PPV23-PCV13) and non-vaccine types (NVTs) increased significantly (IRR 2·17, P = 0·0002 and IRR 3·43, P = 0·0001 respectively). Consequently, the overall IPD incidence rate in adults has remained relatively unchanged (from 28·66/100 000 to 28·88/100 000, IRR 1·01, P = 0·9477). Serotype 19A and NVTs were mainly responsible for penicillin resistance in recent years. The decline of PCV7 serotypes indicate that the introduction of PCV7 resulted in herd-protection for adults. However, increases in PPV23-PCV13 and NVTs suggest that changes in vaccination strategy amongst older adults are needed to build on the success of PCVs in children. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|